NCT01880931View on ClinicalTrials.gov

The Effect Site Concentration of Remifentanil for Preventing QTc Interval Prolongation During Intubation in Normotensive and Hypertensive Patients

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Intubation, Intratracheal
Interventions
DRUG

Remifentanil

The effect site concentration of remifentanil

Trial Locations (1)

Unknown

Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Severance Hospital

OTHER

NCT01880931 - The Effect Site Concentration of Remifentanil for Preventing QTc Interval Prolongation During Intubation in Normotensive and Hypertensive Patients | Biotech Hunter | Biotech Hunter